New 52 Week Low Today

Boundless Bio Inc BOLD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
9.35quote price arrow up+0.30 (+3.31%)
Volume
107,868
52 week range
8.53 - 15.24
Loading...
  • Open9.06
  • Day High9.42
  • Day Low8.53
  • Prev Close9.05
  • 52 Week High15.24
  • 52 Week High Date03/28/24
  • 52 Week Low8.53
  • 52 Week Low Date05/03/24

Key Stats

  • Market Cap207.938M
  • Shares Out22.24M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open9.06
  • Day High9.42
  • Day Low8.53
  • Prev Close9.05
  • 52 Week High15.24
  • 52 Week High Date03/28/24
  • 52 Week Low8.53
  • 52 Week Low Date05/03/24
  • Market Cap207.938M
  • Shares Out22.24M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-2.22
  • P/E (TTM)-4.21
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-53.796M
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Boundless Bio, Inc. is a clinical-stage oncology company, which is engaged in cancer therapeutics that addresses the unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA). Using its proprietary Spyglass platform, it identifies targets essential for ecDNA functionality in oncogene amplified cancer cells, then designs and develops small molecule drugs called ecDNA-directed therapeutic candidates (ecDTx) to inhibit those targets. Its...
Jonathan Lim M.D.
Chairman of the Board
Zachary Hornby
President, Chief Executive Officer, Director
Jami Rubin
Chief Financial Officer
Address
9880 Campus Point Drive, Suite 120
San Diego, CA
92121
United States